Former Accretive CEO joins Verscend Technologies: 7 things to know

Verscend Technologies, formerly known as Verisk Health, named Emad Rizk, MD, CEO.

Advertisement

Here are seven things to know about Dr. Rizk.

1. He is a healthcare industry senior executive with more than 25 years of experience working closely with payers and government entities.

2. Most recently, Dr. Rizk was CEO of Chicago-based Accretive Health, a revenue cycle services and physician advisory services provider. He also served as a member of its board of directors.

3. He stepped down from his positions at Accretive in May, less than six months after St. Louis-based Ascension Health and TowerBrook Capital Partners agreed to invest $200 million in Accretive. Under the contract, which was finalized in February, Accretive will exclusively provide revenue cycle and physician advisory services to Ascension’s hospitals.

4. Prior to joining Accretive Health, he was president of McKesson Health Solutions.

5. Before then, Dr. Rizk was senior partner and global director of medical management/pharmacy for Deloitte Consulting.

6. He is a lecturer at Wharton, Harvard, MIT, Columbia and the Kellogg Graduate School of Management.

7. Dr. Rizk is currently a board member of the National Association for Hispanic Health; Accuray; and Intarcia Therapeutics.

 

More articles on executive moves:
Mercy Health System names Catherine Weaver SVP for mission integration: 3 points
Cardon Children’s Medical Center appoints Justin Bradshaw CEO: 4 notes
22 latest hospital, health system executive moves

Advertisement

Next Up in Executive Moves

  • Minneapolis-based University of Minnesota Physicians named Greg Beilman, MD, CEO. Dr. Beilman will lead M Physicians, the clinical practice of…

  • Cincinnati-based Mercy Health has promoted Michele Stokes, MSN, to chief nursing officer of its Cincinnati market. Ms. Stokes assumed the…

Advertisement

Comments are closed.